NanoSight

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

Malvern Instruments acquires NanoSight

Extending its solutions for customers working at the nanoscale
Packaging

Queen’s Awards to Enterprise 2013 winners announced

Suppliers to the pharmaceutical sector are recognised for International Trade and Innovation
Research & Development

Nanoparticle tracking system characterises polymer nanoparticles used as drug carriers

Used by a team at Saarland University, Saarbrücken, Germany
Research & Development

Viral count for vaccines

<p>Knowing viral concentrations increases our understanding of the behaviour of some vaccines. Andrew Malloy, head of Applications Sciences, NanoSight, explains how nanoparticle tracking analysis can quantify viral content </p>
Sustainability

NanoSight to supply instrumentation for Oxford University cellular nanoparticle study

<p>NanoSight, a UK manufacturer of nanoparticle characterisation technology, is involved in the development new instrumentation and methodologies aimed at measuring cellular nanoparticles in plasma and urine as biomarkers of a broad range of human diseases.</p>
Sustainability

NanoSight launches super-sensitive nanoparticle characterisation system

<p>NanoSight, the UK nanoparticle characterisation company, has released a new super-sensitive system, the LM10-HS, to compliment its instruments for imaging and sizing nanoparticles in liquid suspension. </p>
Design & Build

NanoSight receives 100th system order for nanoparticle tracking analysis system

<p>NanoSight, the nanoparticle characterisation company, has recently received its 100th purchase order for the unique nanoparticle tracking analysis system that counts individual particles in liquid.</p>
Subscribe now